Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples